The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Benperidol. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Acetophenazine. The serum concentration of Zolmitriptan can be increased when it is combined with Deferasirox. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Protriptyline. The metabolism of Zolmitriptan can be decreased when combined with Benmoxin. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pipamperone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bromperidol. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fencamfamine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine. Tedizolid Phosphate may increase the serotonergic activities of Zolmitriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Selegiline. The risk or severity of adverse effects can be increased when Trazodone is combined with Zolmitriptan. The risk or severity of adverse effects can be increased when Vilazodone is combined with Zolmitriptan. The metabolism of Zolmitriptan can be decreased when combined with Phenoxypropazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Linezolid. The serum concentration of Zolmitriptan can be increased when it is combined with Peginterferon alfa-2b. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlorpromazine. The metabolism of Zolmitriptan can be decreased when combined with Furazolidone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prothipendyl. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Quetiapine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prochlorperazine. The metabolism of Zolmitriptan can be decreased when combined with Dosulepin. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Naratriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cariprazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Almotriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ergotamine. The serum concentration of Zolmitriptan can be decreased when it is combined with Teriflunomide. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Phenelzine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Procarbazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Triflupromazine. The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zolmitriptan. The risk or severity of adverse effects can be increased when Vortioxetine is combined with Zolmitriptan. The metabolism of Zolmitriptan can be decreased when combined with Pivhydrazine. The metabolism of Zolmitriptan can be decreased when combined with Nialamide. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Droperidol. The metabolism of Zolmitriptan can be decreased when combined with Ticlopidine. The metabolism of Zolmitriptan can be decreased when combined with Rucaparib. The metabolism of Zolmitriptan can be decreased when combined with Lobeglitazone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lithium. The metabolism of Zolmitriptan can be decreased when combined with Toloxatone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dapiprazole. The metabolism of Zolmitriptan can be decreased when combined with Azithromycin. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ergoloid mesylate. The risk or severity of adverse effects can be increased when Tramadol is combined with Zolmitriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bromocriptine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiothixene. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Risperidone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluphenazine. The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Promethazine. The serum concentration of Zolmitriptan can be decreased when it is combined with Cyproterone acetate. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Perazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amisulpride. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Nefazodone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ecopipam. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thioproperazine. Zolmitriptan may increase the hypertensive activities of Droxidopa. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Imipramine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Perphenazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mesoridazine. Methylergometrine may increase the vasoconstricting activities of Zolmitriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Cyclobenzaprine. The serum concentration of Zolmitriptan can be increased when it is combined with Amphetamine. The metabolism of Zolmitriptan can be decreased when combined with Pargyline. The serum concentration of Zolmitriptan can be increased when it is combined with Abiraterone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bifeprunox. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paliperidone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram. The metabolism of Zolmitriptan can be decreased when combined with Iproclozide. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Milnacipran. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sertraline. The metabolism of Zolmitriptan can be decreased when combined with Pheniprazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Desipramine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pipotiazine. The metabolism of Zolmitriptan can be decreased when combined with Nevirapine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Remoxipride. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zuclopenthixol. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Propericiazine. The metabolism of Zolmitriptan can be decreased when combined with Hydracarbazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amitriptyline. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tetrahydropalmatine. The serum concentration of Zolmitriptan can be increased when it is combined with Propranolol. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pimozide. The metabolism of Zolmitriptan can be decreased when combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dihydroergotamine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlorprothixene. The metabolism of Zolmitriptan can be decreased when combined with Mexiletine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Promazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ritanserin. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Isocarboxazid. The risk or severity of adverse effects can be increased when Dapoxetine is combined with Zolmitriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tapentadol. The metabolism of Zolmitriptan can be decreased when combined with Methylene blue. The serum concentration of Zolmitriptan can be increased when it is combined with Harmaline. The metabolism of Zolmitriptan can be decreased when combined with Trans-2-Phenylcyclopropylamine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amperozide. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Desvenlafaxine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Aceprometazine. The metabolism of Zolmitriptan can be decreased when combined with Lidocaine. The metabolism of Zolmitriptan can be decreased when combined with Iproniazid. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sumatriptan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Trifluoperazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Loxapine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Duloxetine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thioridazine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tiapride. The metabolism of Zolmitriptan can be decreased when combined with Simeprevir. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Moclobemide. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ergonovine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pethidine. The metabolism of Zolmitriptan can be decreased when combined with Clotrimazole. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sertindole. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ziprasidone. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mirtazapine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Molindone. The metabolism of Zolmitriptan can be decreased when combined with Tenofovir disoproxil. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Maprotiline. Dolasetron may increase the serotonergic activities of Zolmitriptan. The serum concentration of Zolmitriptan can be increased when it is combined with Vemurafenib. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dextromethorphan. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Reserpine. The metabolism of Zolmitriptan can be decreased when combined with Octamoxin. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Melperone. The metabolism of Zolmitriptan can be decreased when combined with Zucapsaicin. The risk or severity of adverse effects can be increased when Cabergoline is combined with Zolmitriptan. The metabolism of Zolmitriptan can be decreased when combined with Safrazine. The metabolism of Zolmitriptan can be decreased when combined with Caffeine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lorcaserin. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Tranylcypromine. The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zotepine.